Worth repeating for folks like me. "If Leronlim
Post# of 146038
" If Leronlimab is technically conjugated to another drug there is no guarantee that the conformation of the molecule (how it is folded in three dimensional space) that allows for the adept interaction with the CCR5 receptor, will remain intact without further testing. Far easier and more likely is that the drugs will simply be administered separately as part of a treatment protocol.
Investors Hangout: https://investorshangout.com/post/view?id=671...z8k2m2mnYD
Thanks, as usual for the plain spoken science.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)